Immunic Inc (IMUX)

NASDAQ HEALTHCARE
$10.03 -6.70% RSI 47 Neutral Add Alert

Moving Averages

SMA 200
$0.85
Price above

Company Profile

Immunic, Inc., a clinical-stage biopharmaceutical company, develops a line of selective oral immunology therapies for the treatment of chronic autoimmune and inflammatory diseases. The company is headquartered in New York, New York.

Sector
HEALTHCARE
Industry
BIOTECHNOLOGY
Market Cap
$152.64M
P/E Ratio
None
EPS
$-0.62
Beta
1.372
Dividend Yield
0.00%
52-Week High
$1.51
52-Week Low
$0.506

Similar stocks in BIOTECHNOLOGY

BNTX
BioNTech SE
RSI 57.0
VRTX
Vertex Pharmaceuticals Inc
RSI 41.0
CRSP
CRISPR Therapeutics AG
RSI 50.0
RXRX
Recursion Pharmaceuticals Inc - Class A
RSI 50.0
MRNA
Moderna Inc
RSI 36.0
VKTX
Viking Therapeutics Inc
RSI 38.0

Data last updated: April 11, 2026 at 7:49 AM EDT

Track IMUX for free

Get e-mail RSI alerts when Immunic Inc enters oversold or overbought territory. Free forever.

Add Alert